John N. Kapoor, Director, Officer, 10% Owner, President & CEO at Insys Therapeutics, Inc. (INSY), bought 5,700 shares at $18.57 ($106K) on 2016-08-12, disclosed to the SEC on 2016-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AKRX | BUY | 2015-03-10 | $841K | — | Filing → |
| AKRX | SELL | 2014-12-12 | $2.1M | — | Filing → |
| AKRX | SELL | 2014-08-27 | $1.9M | — | Filing → |